grantGrants.gov

Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)

Organization National Institutes of HealthPosted 6 Nov 2024Deadline 7 Jan 2028
HHS-NIH1193.393synopsis
Sign up free to applyFree account · Full description · Apply link · All opportunity types

Full Description

Opportunity Number: PAR-25-145 Document Type: synopsis CFDA Numbers: 93.393

Read the full description

Sign up freeFree account · No credit card required
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) — National Institutes of Health | Dev Procure